Life Telegraph
  • Home
  • Top News
  • Stock Research
  • Market Coverage
  • Earnings And Estimates
No Result
View All Result
Life Telegraph
  • Home
  • Top News
  • Stock Research
  • Market Coverage
  • Earnings And Estimates
No Result
View All Result
Life Telegraph
No Result
View All Result
Home Market

Look For Institutional Buying In Diebold Nixdorf Incorporated (NYSE: DBD)

March 17, 2023
in Market

Millennium Management LLC has recently announced that it has increased stake in Diebold Nixdorf Incorporated (NYSE:DBD) by 400.85%. After grabbing 3.96 million shares, the institutional investor is now in possession of 3.17 million shares of the Technology Company. The new investment brought the stake of investor firm to 5.01% having worth around $12.75 million. Moreover, Sapience Investments LLC increased its share by 1.4 million to have a control over 3.87 million shares. And Prescott Group Capital Management raised its holdings to 2.8 million shares by acquiring 2.81 million shares or 3.55% of the stake.

Diebold Nixdorf Incorporated (DBD) concluded trading on 03/16/23 at a closing price of $2.30, with 1.65 million shares of worth about $3.79 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.35% during that period and on Thursday the price saw a loss of about -2.13%. Currently the company’s common shares owned by public are about 79.10M shares, out of which, 71.41M shares are available for trading.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".

Sponsored

A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 5 analysts are covering the DBD stock and their offered price forecasts bring an average price target of $4.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $5.00 and could fall to a lowest price of $3.00. The stock’s current price level is 42.5% above of average price target set by the analysts, while a rise to estimated low would result in gain of 23.33% for the stock. However, touching the estimated high of $5.00 would mean a gain of 54.0% for the stock.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 100 times over the past 12 months. They bought 1,286,904 shares in 77 of the transactions. In 23 selling transactions, insiders dumped 116,942 shares.

Vanguard Total Stock Market Index, iShares Russell 2000 ETF, and 1290 VT GAMCO Small Company Value are the top 3 mutual funds which are holding stakes in Diebold Nixdorf Incorporated Vanguard Total Stock Market Index is currently holding 2.62 million shares of worth totaling $8.45 million. The company recently came buying 0.1 million shares which brought its stake up to 3.32% of the company’s outstanding shares. iShares Russell 2000 ETF sold 5238.0 shares, after which its hold over company’s outstanding shares shrunk to 2.09%, leaving 1.65 million shares with the mutual fund that have a worth of about $5.32 million. 1290 VT GAMCO Small Company Value, after selling 0.97 million shares, have now control over 1.23% of the stake in the company. It holds -0.41 million shares of worth $3.14 million.

Diebold Nixdorf Incorporated (NYSE: DBD) started trading at $2.40, above $0.05 from concluding price of the previous day. However, the stock later moved at a day high price of 2.4300, or with a loss of -2.13%. Stock saw a price change of -23.84% in past 5 days and over the past one month there was a price change of -16.97%. Year-to-date (YTD), DBD shares are showing a performance of 61.97% which decreased to -67.65% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.26 but also hit the highest price of $7.60 during that period. The average intraday trading volume for Diebold Nixdorf Incorporated shares is 1.87 million. The stock is currently trading -23.69% below its 20-day simple moving average (SMA20), while that difference is down -8.07% for SMA50 and it goes to -13.88% lower than SMA200.

Millennium Management LLC acquired 3.96 million shares of Diebold Nixdorf Incorporated having value of about $12.75 million. Data submitted at the U.S SEC by Millennium Management LLC revealed that the firm now holds 3.17 million shares in the company valued at close to $7288897.8, or have control over 400.85% stake in the company. Diebold Nixdorf Incorporated (NYSE: DBD) currently have 79.10M outstanding shares and institutions hold larger chunk of about 77.20% of that. Holding of mutual funds in the company is about 45.10% while other institutional holders and individual stake holders have control over 9.30% and 22.61% of the stake respectively.

The stock has a current market capitalization of $201.92M and its 3Y-monthly beta is at 3.04. It has posted earnings per share of -$7.36 in the same period. It has Quick Ratio of 0.30. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DBD, volatility over the week remained 11.09% while standing at 9.85% over the month.

Analysts are in expectations that Diebold Nixdorf Incorporated (DBD) stock would likely to be making an EPS of $0.18 in the current quarter, while forecast for next quarter EPS is $0.29 and it is $2.24 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.04 which is $0.32 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$1.61 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 71.00% while it is estimated to increase by 41.50% in next year. EPS is likely to shrink at an annualized rate of 3.00% for next 5-years, compared to annual growth of 17.00% made by the stock over the past 5-years.

Analysts at 5 brokerage firms have issued recommendations for the Diebold Nixdorf Incorporated (DBD)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.60. Out of those 5 Wall Street analysts, 1 recommended a “Buy” rating, while 2 were in favor recommending the stock as a “Hold” and 1 analyst recommended the stock as “Sell”.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by DA Davidson on October 24, 2022 offering a Neutral rating for the stock and assigned a target price range of between $5 and $3 to it. Stock get a Neutral rating from Wedbush on June 21, 2021.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance

Gains May Be On The Menu For Athenex Inc. (NASDAQ: ATNX)

by Annabelle Farmer
March 22, 2023
0

Millennium Management LLC recently announced the acquisition of new stake in Athenex Inc. (NASDAQ:ATNX). The institutional investor has increased its...

Inari Medical Inc. (NARI): Street Finally Waking Up

March 22, 2023

Iris Energy Limited (NASDAQ: IREN) Seen Running Too Hot, Let’s Look At This More Closely

March 22, 2023

These Numbers Could Change Investor Views For Flora Growth Corp. (NASDAQ: FLGC)

March 22, 2023

BioLineRx Ltd. (BLRX) Volatility Spurs A Quest For Clarity

March 22, 2023

DaVita Inc. (NYSE: DVA) Loses -37.34% From High. Why That Could Change?

March 22, 2023
fav

Categories

  • Market
  • Finance
  • Industry
  • Top News
  • Stock Research
  • Market Coverage
  • Earnings And Estimates

Company

  • Home
  • About Us
  • Our Team
  • Contact Us

Recent Posts

  • Gains May Be On The Menu For Athenex Inc. (NASDAQ: ATNX)
  • Inari Medical Inc. (NARI): Street Finally Waking Up
  • Iris Energy Limited (NASDAQ: IREN) Seen Running Too Hot, Let’s Look At This More Closely

Copyright © 2022 Life Telegraph.

No Result
View All Result
  • Home
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

Copyright © 2022 Life Telegraph.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?